Vanderbilt Womens Heart and Neurology Symposium

  21 Mar 2025 - 21 Mar 2025

   Franklin, TN, United States

conference-img

Vanderbilt Womens Heart and Neurology Symposium

21 Mar 2025

 - 

21 Mar 2025

Franklin, TN, United States



This symposium will provide a unique, case-based educational program to strengthen clinical knowledge of cardiovascular and neurologic care for female patients across their life course. Expert faculty from Vanderbilt University Medical Center will discuss key issues in the care of both reproductive age and post-menopausal patients

Hypertension Management in Women; Medical Weight Loss Autonomic Dysfunction; Hormone Replacement Therapy in Medically Complex Patients; Contraception Counseling for Patients with Cardiovascular and Neurologic Conditions Cognitive Function in Women; Coronary Microvascular Dysfunction; Managing Epilepsy, Migraines and MS in Pregnancy

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot